tiprankstipranks
DMK Pharmaceuticals (GB:0A4X)
LSE:0A4X
UK Market

DMK Pharmaceuticals (0A4X) Technical Analysis

Compare
0 Followers

Technical Sentiment

Overall Consensus
Strong Sell
4Bullish
0Neutral
13Bearish
Technical Analysis Consensus
Strong Sell
1Bullish
0Neutral
4Bearish
Moving Average Consensus
Strong Sell
3Bullish
0Neutral
9Bearish
DMK Pharmaceuticals’s (0A4X) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting DMK Pharmaceuticals is a Sell.
DMK Pharmaceuticals’s (0A4X) 20-Day exponential moving average is 0.01, while DMK Pharmaceuticals’s (0A4X) share price is <$0.1, making it a Sell.
DMK Pharmaceuticals’s (0A4X) 50-Day exponential moving average is 0.01, while DMK Pharmaceuticals’s (0A4X) share price is <$0.1, making it a Sell.

DMK Pharmaceuticals (0A4X) Pivot Points

Mar 10, 2025, 07:53 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Fibonacci
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

DMK Pharmaceuticals (0A4X) Moving Averages

Mar 10, 2025, 07:53 PM
Period
Simple
Exponential
MA5
0.01Buy
0.01Sell
MA10
0.01Sell
0.01Sell
MA20
0.01Sell
0.01Sell
MA50
0.01Buy
0.01Sell
MA100
0.01Buy
0.01Sell
MA200
0.02Sell
0.02Sell
DMK Pharmaceuticals’s (0A4X) 10-Day exponential moving average is 0.01, while DMK Pharmaceuticals’s (0A4X) share price is <$0.1, making it a Sell.
DMK Pharmaceuticals’s (0A4X) 100-Day exponential moving average is 0.01, while DMK Pharmaceuticals’s (0A4X) share price is <$0.1, making it a Sell.
DMK Pharmaceuticals’s (0A4X) stock price is <$0.1 and DMK Pharmaceuticals’s (0A4X) 50-day simple moving average is 0.01, creating a Buy signal.
DMK Pharmaceuticals’s (0A4X) stock price is <$0.1 and DMK Pharmaceuticals’s (0A4X) 100-day simple moving average is 0.01, creating a Buy signal.
DMK Pharmaceuticals’s (0A4X) stock price is <$0.1 and DMK Pharmaceuticals’s (0A4X) 200-day simple moving average is 0.02, creating a Sell signal.

DMK Pharmaceuticals (0A4X) Technical Indicators

Mar 10, 2025, 07:53 PM
Name
Value
Implied Action
RSI (14)
6.18
Buy
STOCH (9,6)
0.00
-
STOCHRSI (14)
0.00
-
MACD (12,26)
>-0.01
Sell
ADX (14)
84.97
Sell
Williams %R
-
CCI (14)
0.00
-
ATR (14)
<0.01
-
Ultimate Oscillator
-16.62
Sell
ROC
0.00
-
DMK Pharmaceuticals’s (0A4X) Relative Strength Index (RSI) is 6.18, creating a Buy signal.
DMK Pharmaceuticals’s (0A4X) Trend Strength Indicator (ADX) is 84.97, creating a Sell signal.

FAQ

Is 0A4X a Buy, Hold, or Sell?
Based on 0A4X’s technical indicators, 0A4X is a Strong Sell.
    What is 0A4X’s RSI (14)?
    0A4X’s RSI (14) is 6.18, which suggests 0A4X is a Buy.
      What is 0A4X’s MACD?
      0A4X’s MACD is >-0.01, which suggests 0A4X is a Sell.
        What is 0A4X’s 5-day moving average?
        0A4X’s 5-day moving average is 0.01, which suggests 0A4X is a Buy.
          What is 0A4X’s 20-day moving average?
          0A4X 20-day moving average is 0.01, which suggests 0A4X is a Sell.
            What is 0A4X’s 50-day moving average?
            0A4X’s 50-day moving average is 0.01, which suggests 0A4X is a Buy.
              What is 0A4X’s 200-day moving average?
              0A4X’s 200-day moving average is 0.02, which suggests 0A4X is a Sell.
                What is 0A4X’s Williams % R (14)?
                Currently, no data Available
                What is 0A4X’s CCI (14)?
                Currently, no data Available
                What is the share price of DMK Pharmaceuticals?
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis